Proceedings from the Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Immune and Cellular Therapy in Multiple Myeloma is a research paper published in Transplantation and Cellular Therapy (2022). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: R01 CA248493
National Cancer Institute
Grant: R01 CA252937
National Institutes of Health
Grant: U10HL069294
National Institutes of Health
Grant: U24HL138660
European Hematology Association
Grant: TRTH207
NCI NIH HHS
Grant: K08 CA245100
NCI NIH HHS
Grant: R37 CA252040
Cancer Research UK
Grant: RCCCSF-Nov21\100004
NHLBI NIH HHS
Grant: UG1 HL069315
Medical Research Council
Grant: MR/S001883/1
National Institutes of Health
Grant: 5U10HL069294-13
Blood & Marrow Transplant Clinical Trials Network Data Coordinating Center
National Institutes of Health
Grant: 1U24HL138660-01
Blood and Marrow Transplant Clinical Trials Network Data Coordinating Center
National Institutes of Health
Grant: 1R01CA252937-01
Tumor matrix remodeling in anti-myeloma immunity and immunotherapy
National Institutes of Health
Grant: 5R01CA248493-05
Exploring CD38 molecular biology and imaging in multiple myeloma pathogenesis
National Heart, Lung, and Blood Institute
FWCI
0.15
Citation Percentile
0.5%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals